剖宫产术同时行子宫肌瘤剔除术的临床研究

目的评估剖宫产同时行子宫肌瘤剔除术的安全性和有效性。方法选择2009年1月至2012年6月深圳市龙华人民医院收治的妊娠合并子宫肌瘤孕妇108例为观察组，选择同期行单纯剖宫产术的孕妇69例为对照组，对两组手术及产后情况进行分析。结果观察组手术时间长于对照组，差异有统计学意义（P〈0．05），两组术中出血量、术后48h阴道出血量、血红蛋白下降值、术后肠蠕动恢复时间、手术切口愈合时间、手术后并发症、恶露干净时间的比较，差异无统计学意义（P〉0．05）；5cm≤直径≤8cm组产妇术中平均出血量、术后48h阴道出血量和血红蛋白下降值虽然稍高于直径〈5cm组，但两组比较差异无统计学意义（P〉0．05）。结论剖宫产同时行子宫肌瘤剔除术，不会增加产后出血、产褥感染等风险，是安全可靠的。

Clinical Research of Myomectomy during Cesarean Section

Objective To evaluate the safety and efficacy of myomectomy during Cesarean section. Methods From Jan. 2009 to Jun. 2012 in Longhua People＇s Hospital of Shenzhen, 108 pregnant women with uterine fibroids were studied as the observation group ,69 pregnant women of Cesarean section alone were studied as a control group, surgical and post-natal conditions of the two groups were analysed. Results The operative time was longer in the observation group than the control group with statistically significant differ- ence（ P 〈0.05 ）, and blood loss, the amount of vaginal bleeding 48 h after Cesarean section, hemoglobin decrease value, postoperative bowel recovery time, the surgical incision healing time, post-operative complica- tions, lochia clean time were not statistically significantly different between the two groups （ P 〉 0.05 ）. The average blood loss, the amount of vaginal bleeding 48 h after Cesarean section and hemoglobin decreased value were slightly higher in 5 cm≤diameter≤8 cm group than the diameter 〈5 cm group,but not statisti- cally significant（ P 〉 0.05）. Conclusion Myomectomy during Cesarean section does not increase postpar- tum hen~orrhage and puerperal infection risk, which is safe and effective.